MADRID -- Remote screening yielded new cases of atrial fibrillation (Afib or AF) in the general population that otherwise would have gone undetected and untreated, according to the AMALFI trial in the ...

iRhythm's ZIO XT Patch wearable sensor is worn by patients to help diagnose arrhythmias. Though iRhythm's product, the ZIO XT Patch, combines two buzzy technologies—remote monitoring and a ...

iRhythm Technologies, Inc., a leading digital health care solutions company focusing on the advancement of cardiac care, presented study results that demonstrate high compliance among patients using ...

iRhythm Technologies' stock took another nosedive Monday after Medicare Administrative Contractor (MAC) Novitas Solutions updated its reimbursement rates over the weekend for codes that cover ...

iRhythm Technologies, Inc., a leading digital health care solutions company focusing on the advancement of cardiac care, presented study results that demonstrate high compliance among patients using ...

SAN FRANCISCO, Nov. 06, 2022 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading cardiovascular diagnostics and digital healthcare solutions company focused on creating trusted ...

SAN FRANCISCO, Sept. 09, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) today announced initial research findings on post-market, real-world performance of Zio® monitor, its ...

(HealthDay)—The common but dangerous heart rhythm disorder known as atrial fibrillation—or a-fib—can go undetected for years. Now, research suggests a high-tech, wearable patch might spot the ...

SAN FRANCISCO, July 10, 2018 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced ...

Zio XT (iRhythm Technologies) is an ambulatory heart monitoring service, designed to detect cardiac arrythmias in people with infrequent symptoms (every 24 hours or longer). It is comprised of the Zio ...